Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | 23ME-00610 |
Trade Name | |
Synonyms | 23ME00610|23ME 00610 |
Drug Descriptions |
23ME-00610 is a monoclonal antibody targeting CD200R1, which potentially results in increased antitumor immune response (Cancer Res 2022;82(12_Suppl):Abstract nr 602). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C186674 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
23ME-00610 | 23ME-00610 | 0 | 1 |